11 Others have confirmed that GH action is lower in patients with MASH [12] including significantly lower levels of IGF-1, IGF-2, and the ratio of IGF-1 to IGFBP-3. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatohepatitis.